Facebook Pixel Code
About Sickkids
About SickKids

December 6, 2010

Centre for Commercialization of Regenerative Medicine receives $15 million from federal government

Regenerative medicine received an important boost today through a significant investment from the Government of Canada. A $15-million grant was awarded to the Centre for Commercialization of Regenerative Medicine (CCRM), a University of Toronto-hosted project for which The Hospital for Sick Children (SickKids) is a research partner.

The Honourable Tony Clement, Minister of Industry, announced funding for five projects from the Centres of Excellence for Commercialization and Research (CECR) 2010 competition, an initiative of the Government of Canada’s Networks of Centres of Excellence (NCE).

The CCRM is a research and commercialization project that will work to develop products to treat a variety of health conditions – such as spinal cord injuries, cancer, heart disease and diabetes – through stem cell therapy and other forms of regenerative medicine.  SickKids is one of six health-care institutions serving as research partners with U of T and partners from the private sector.

“As leader of the Ontario Stem Cell Initiative, I am delighted with this investment, which will help translate stem cell science into a vibrant and innovative regenerative medicine industry in Canada,” says Dr. Janet Rossant, who is also Chief of Research at SickKids and Professor of Molecular Genetics at the University of Toronto.

The CCRM is also supported by the Ministry of Research and Innovation.

The CECR program aims to create internationally recognized centres of commercialization and research expertise in environmental science and technologies, natural resources and energy, health and related life sciences and technologies, information and communications technologies.